Cancer
Malignant Prostate Neoplasm
CI-CAN-00005927Explore in graph →
Top-level1,377 active trials24 approved drugs58 evidence items
- NCIt
- C7378
- ICD-10
- C61
- DOID
- 10283
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00005927Explore in graph →
Clinical trials
5,981 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (730)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00083005 | Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate | completed | Phase 2 | 60 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT01340599 | Defined Green Tea Catechin Extract in Treating Patients With Localized Prostate Cancer Undergoing Surgery | terminated | Phase 2 | 5 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 15, 2012 |
| clinicaltrials |
| NCT00054977 | Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors | completed | Phase 1 | 40 | Galectin Therapeutics Inc.INDUSTRY | 1 | Mar 12, 2012 | clinicaltrials |
| NCT01048151 | TNFerade Biologic to Treat Locally Advanced Prostate Cancer | unknown | Phase 1 | 20 | GenVecINDUSTRY | 1 | Mar 12, 2012 | clinicaltrials |
| NCT00773318 | SPECT-CT Guided Lymphatic Mapping and Sentinel Lymphadenectomy (LM/SL) in Prostate Cancer | terminated | N/A | 30 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Mar 5, 2012 | clinicaltrials |
| NCT00989105 | Technetium Tc 99m Demobesin-4 for Imaging Procedures in Patients With Prostate Cancer | terminated | Phase 1 | 8 | Cancer Research UKOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT01132599 | Comparing PET-CT Using C-11 Choline and 18F-Fluoromethylcholine in Patients With Metastatic Prostate Cancer | withdrawn | Phase 2 | 0 | Cancer Research UKOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT00585741 | Pilot Study of 18F-FLT PET | terminated | N/A | 15 | University of Wisconsin, MadisonOTHER | 1 | Feb 23, 2012 | clinicaltrials |
| NCT00217516 | Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer | completed | Phase 1 | 18 | Roswell Park Cancer InstituteOTHER | 1 | Feb 9, 2012 | clinicaltrials |
| NCT01530295 | Biochemical Recurrence Rate of Radical Prostatectomy Combined With Neoadjuvant and Adjuvant Chemotherapy in High Risk Prostate Cancer | unknown | N/A | 70 | Hanjong AhnOTHER | 1 | Feb 9, 2012 | clinicaltrials |
| NCT00242918 | Safety and Effectiveness Study of Docetaxel and ZD1839 Followed by Removal of the Prostate to Treat Prostate Cancer | completed | Phase 2 | 29 | Benaroya Research InstituteOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT00736164 | Selenomethionine in Treating Patients Undergoing Surgery or Internal Radiation Therapy for Stage I or Stage II Prostate Cancer | withdrawn | Phase 2 | 0 | Roswell Park Cancer InstituteOTHER | 0 | Feb 6, 2012 | clinicaltrials |
| NCT01325844 | The Effects of Epidural Anesthesia on the Bioavailability of Nitric Oxide and Renal Function in Patients Undergoing Laparoscopic Surgery | completed | N/A | 45 | Yonsei UniversityOTHER | 1 | Feb 6, 2012 | clinicaltrials |
| NCT00426777 | Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer | completed | Phase 3 | 160 | CMX ResearchOTHER | 1 | Feb 3, 2012 | clinicaltrials |
| NCT01525914 | Response of Patients on Surveillance for Prostate Cancer to Dutasteride | completed | — | 100 | Sunnybrook Health Sciences CentreOTHER | 1 | Feb 3, 2012 | clinicaltrials |
| NCT01008969 | Feasibility of Using SPECT/CT Imaging to Map Lymphatic Drainage Patterns in Prostate Cancer Patients | completed | N/A | 10 | University of California, San FranciscoOTHER | 1 | Feb 2, 2012 | clinicaltrials |
| NCT00029224 | Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions | completed | Phase 4 | 500 | NovartisINDUSTRY | 1 | Feb 1, 2012 | clinicaltrials |
| NCT00698711 | Vaccination of Prostate Cancer Patients With MUC-2-KLH Conjugate Plus the Immunological Adjuvant QS21 | completed | Phase 1 | 15 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 31, 2012 | clinicaltrials |
| NCT01132404 | Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448 | terminated | Phase 1 / Phase 2 | 9 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Jan 31, 2012 | clinicaltrials |
| NCT00581724 | Pain in Cancer Survivors | completed | — | 200 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 26, 2012 | clinicaltrials |
| NCT00126165 | Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer | completed | Phase 1 / Phase 2 | 72 | Alberta Health servicesOTHER | 1 | Jan 19, 2012 | clinicaltrials |
| NCT00526331 | Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy | completed | Phase 4 | 49 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 16, 2012 | clinicaltrials |
| NCT01078545 | Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)(LEMON) | completed | — | 729 | AbbottINDUSTRY | 2 | Jan 16, 2012 | clinicaltrials |
| NCT01510288 | Phase 1 Trial of Ipilimumab and GVAX in Patients With Metastatic Castration-resistant Prostate Cancer | terminated | Phase 1 | 28 | Amsterdam UMC, location VUmcOTHER | 1 | Jan 16, 2012 | clinicaltrials |
| NCT00705835 | Vaccine Therapy of Prostate Cancer Patients With Recombinant Soluble Prostate-Specific Membrane Antigen (Rs-PSMA) Plus the Immunological Adjuvant Alhydrogel | completed | Phase 1 | 14 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 9, 2012 | clinicaltrials |
| NCT01492270 | Imaging for Significant Prostate Cancer Risk Evaluation(PICTURE) | unknown | N/A | 126 | University College London HospitalsOTHER | 1 | Dec 30, 2011 | clinicaltrials |
| NCT00116779 | A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer | completed | Phase 2 | 127 | Ferring PharmaceuticalsINDUSTRY | 2 | Dec 19, 2011 | clinicaltrials |
| NCT01487902 | The Role of Androgen Deprivation Treatment (ADT) in Docetaxe-Prednisolone Chemotherapy for Castrate-Resistant Prostatic Cancer | unknown | Phase 2 | 90 | Asan Medical CenterOTHER | 1 | Dec 8, 2011 | clinicaltrials |
| NCT00550810 | Sutent Maintenance After Response to Taxotere(SMART) | unknown | Phase 2 | 30 | Alberta Health servicesOTHER | 1 | Dec 7, 2011 | clinicaltrials |
| NCT01478412 | An Evaluation of Polymer Based Fiducials for Use in Imaging Patients Receiving Treatment for Prostate Cancer(Clarity) | unknown | — | 20 | John Chang, MDOTHER | 1 | Dec 7, 2011 | clinicaltrials |
| NCT01153113 | Human Telomerase Reverse Transcriptase Messenger RNA (hTERT mRNA) Transfected Dendritic Cell Vaccines | withdrawn | Phase 1 / Phase 2 | 0 | University of FloridaOTHER | 0 | Dec 2, 2011 | clinicaltrials |
| NCT01484808 | The Utility of PSADv (PSA Density Velocity) While on Dutasteride for Predicting Prostate Cancer Incidence and Grade and Stage(PSADv) | unknown | — | 6,600 | University Urological Associates Inc.OTHER | 1 | Dec 2, 2011 | clinicaltrials |
| NCT00441532 | Study On Lidocaine Vs. Placebo Pain Control During Transrectal Ultrasound Guided Prostate Biopsy | completed | N/A | 50 | Corewell Health EastOTHER | 1 | Nov 23, 2011 | clinicaltrials |
| NCT01191099 | Comprehensive Analysis of Hypoxia in Prostate Cancer: Diagnostic Markers and Prognostic Significance | unknown | — | 150 | University of ZurichOTHER | 1 | Nov 8, 2011 | clinicaltrials |
| NCT00973882 | Carboplatin-Etoposide Combination in Hormone-Resistant Prostate Cancers | completed | Phase 2 | 60 | Centre Leon BerardOTHER | 1 | Nov 3, 2011 | clinicaltrials |
| NCT01275872 | Effect of Guided Imagery and Progressive Muscle Relaxation as a Means to Improve the Psychological Well-being and the Quality of Life for Patients With Breast and Prostate Cancer | completed | N/A | 200 | Cyprus University of TechnologyOTHER | 1 | Nov 1, 2011 | clinicaltrials |
| NCT00577876 | Assessment of the Functional Significance of Accessory Pudendal Arteries | completed | N/A | 38 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 27, 2011 | clinicaltrials |
| NCT00005857 | Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy | completed | Phase 2 | — | City of Hope Medical CenterOTHER | 1 | Oct 20, 2011 | clinicaltrials |
| NCT00036075 | Study Using CP-461 to Treat Advanced Prostate Cancer | completed | Phase 2 | 25 | Astellas Pharma IncINDUSTRY | 1 | Oct 17, 2011 | clinicaltrials |
| NCT00582543 | MRI/MRSI in Risk Assessment of Prostate Cancer Patients | completed | N/A | 357 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 17, 2011 | clinicaltrials |
| NCT00622973 | USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases | completed | Phase 3 | 130 | Insel Gruppe AG, University Hospital BernOTHER | 1 | Oct 12, 2011 | clinicaltrials |
| NCT00712829 | Study to Evaluate the Safety, Pharmacokinetics, Tissue Distribution, Metabolism and Dosimetry of Two Prostate Cancer Imaging Agents | completed | Phase 1 | 12 | Molecular Insight Pharmaceuticals, Inc.INDUSTRY | 1 | Oct 12, 2011 | clinicaltrials |
| NCT00992745 | A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancer | completed | Phase 1 | 24 | Molecular Insight Pharmaceuticals, Inc.INDUSTRY | 1 | Oct 12, 2011 | clinicaltrials |
| NCT00129025 | Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer | completed | Phase 1 / Phase 2 | 35 | Alberta Health servicesOTHER | 1 | Oct 10, 2011 | clinicaltrials |
| NCT01448798 | Athermal Nerve-sparing During Robotic-assisted Radical Prostatectomy Using a Hemostatic Matrix.(AnPro) | unknown | N/A | 50 | Johann Wolfgang Goethe University HospitalOTHER | 1 | Oct 7, 2011 | clinicaltrials |
| NCT01440855 | Evaluation of the Efficacy of National Cancer Institute's Facing Forward Booklet in the Cancer Community Setting | completed | N/A | 340 | Fox Chase Cancer CenterOTHER | 1 | Oct 4, 2011 | clinicaltrials |
| NCT00335491 | Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors | completed | N/A | 49 | University of UtahOTHER | 1 | Sep 30, 2011 | clinicaltrials |
| NCT00741364 | Vitamin D Effects on Prostate Pathology(DProstate) | unknown | Phase 2 | 90 | University of TorontoOTHER | 1 | Sep 30, 2011 | clinicaltrials |
| NCT00380055 | Reducing Cancer Disparities for American Indians in the Rural Intermountain West | completed | N/A | 1,800 | University of UtahOTHER | 1 | Sep 21, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Mar 15, 2012source: clinicaltrials